Keywords
Last Name

Samantha Parker, PhD

TitleAssistant Professor
InstitutionBoston University School of Public Health
DepartmentEpidemiology
Address715 Albany Street T425E
Boston MA 02118
Phone(617) 638-7741
ORCID ORCID Icon0000-0002-7193-077X
 Research Expertise & Professional Interests
Dr. Parker is an Assistant Professor in the Department of Epidemiology at Boston University School of Public Health. Her research interests include understanding the relationship between prenatal exposures and infant and childhood outcomes and the role of adverse pregnancy outcomes in maternal health. Dr. Parker is the Principal Investigator on a K-01 award from the National Heart, Lung, and Blood Institute (NHLBI) to investigate the role of adverse pregnancy outcomes in the development of coronary heart disease. She served as a consultant for the Centers for Disease Control and Prevention (CDC) Zika Response in 2016. She was awarded the Tyroler Lilienfeld Award (2014) by the Society of Epidemiologic Research for her dissertation work on preeclampsia. She received her Ph.D. from Boston University, where she was a trainee on the Boston University Reproductive, Perinatal, and Pediatric Training Grant, and her MSPH from Emory University. She has also previously worked at the Massachusetts Department of Public Health and the Slone Epidemiology Center at Boston University. Dr. Parker teaches Intermediate Epidemiology and Applications of Intermediate Epidemiology.

 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Werler MM, Parker SE, Hedman K, Gissler M, Ritvanen A, Surcel HM. Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring. Am J Epidemiol. 2016 Dec 15; 184(12):902-912. PMID: 27856447.
    View in: PubMed
  2. Cragan JD, Isenburg JL, Parker SE, Alverson CJ, Meyer RE, Stallings EB, Kirby RS, Lupo PJ, Liu JS, Seagroves A, Ethen MK, Cho SJ, Evans M, Liberman RF, Fornoff J, Browne ML, Rutkowski RE, Nance AE, Anderka M, Fox DJ, Steele A, Copeland G, Romitti PA, Mai CT. Population-based microcephaly surveillance in the United States, 2009 to 2013: An analysis of potential sources of variation. Birth Defects Res A Clin Mol Teratol. 2016 Nov; 106(11):972-982. PMID: 27891783.
    View in: PubMed
  3. Parker SE, Lijewski VA, Janulewicz PA, Collett BR, Speltz ML, Werler MM. Upper respiratory infection during pregnancy and neurodevelopmental outcomes among offspring. Neurotoxicol Teratol. 2016 Sep - Oct; 57:54-59. PMID: 27343815.
    View in: PubMed
  4. Benedum CM, Yazdy MM, Parker SE, Mitchell AA, Werler MM. Association of Clomiphene and Assisted Reproductive Technologies With the Risk of Neural Tube Defects. Am J Epidemiol. 2016 Jun 1; 183(11):977-87. PMID: 27188944.
    View in: PubMed
  5. Parker SE, Collett BR, Speltz ML, Werler MM. Prenatal smoking and childhood behavior problems: is the association mediated by birth weight? J Dev Orig Health Dis. 2016 Feb 16; 1-9. PMID: 26880155.
    View in: PubMed
  6. Parker SE, Gissler M, Ananth CV, Werler MM. Induced Abortions and the Risk of Preeclampsia Among Nulliparous Women. Am J Epidemiol. 2015 Oct 15; 182(8):663-9. PMID: 26377957.
    View in: PubMed
  7. Parker SE, Gissler M, Ananth CV, Werler MM. Parker et al. Respond to "Preeclampsia Risk After Induced Abortion". Am J Epidemiol. 2015 Oct 15; 182(8):673-4. PMID: 26377955.
    View in: PubMed
  8. Werler MM, Parker SE. Bias from conditioning on live-births in pregnancy cohorts: an illustration based on neurodevelopment in children after prenatal exposure to organic pollutants (Liew et al. 2015). Int J Epidemiol. 2015 Jun; 44(3):1079-80. PMID: 26163686.
    View in: PubMed
  9. Dawson AL, Razzaghi H, Arth A, Canfield MA, Parker SE, Reefhuis J. Maternal exposures in the National Birth Defects Prevention Study: Time trends of selected exposures. Birth Defects Res A Clin Mol Teratol. 2015 Aug; 103(8):703-12. PMID: 25884728.
    View in: PubMed
  10. Parker SE, Jick SS, Werler MM. Intrauterine device use and the risk of pre-eclampsia: a case-control study. BJOG. 2016 Apr; 123(5):788-95. PMID: 25854682.
    View in: PubMed
  11. Parker SE, Werler MM, Gissler M, Tikkanen M, Ananth CV. Placental abruption and subsequent risk of pre-eclampsia: a population-based case-control study. Paediatr Perinat Epidemiol. 2015 May; 29(3):211-9. PMID: 25761509.
    View in: PubMed
  12. Parker SE, Starr JR, Collett BR, Speltz ML, Werler MM. Nausea and vomiting during pregnancy and neurodevelopmental outcomes in offspring. Paediatr Perinat Epidemiol. 2014 Nov; 28(6):527-35. PMID: 25327160.
    View in: PubMed
  13. Parker SE, Werler MM. Epidemiology of ischemic placental disease: a focus on preterm gestations. Semin Perinatol. 2014 Apr; 38(3):133-8. PMID: 24836824.
    View in: PubMed
  14. Parker SE, Yazdy MM, Mitchell AA, Demmer LA, Werler MM. A description of spina bifida cases and co-occurring malformations, 1976-2011. Am J Med Genet A. 2014 Feb; 164A(2):432-40. PMID: 24357196.
    View in: PubMed
  15. Parker SE, Troisi R, Wise LA, Palmer JR, Titus-Ernstoff L, Strohsnitter WC, Hatch EE. Menarche, menopause, years of menstruation, and the incidence of osteoporosis: the influence of prenatal exposure to diethylstilbestrol. J Clin Endocrinol Metab. 2014 Feb; 99(2):594-601. PMID: 24248183.
    View in: PubMed
  16. Yazdy MM, Mitchell AA, Tinker SC, Parker SE, Werler MM. Periconceptional use of opioids and the risk of neural tube defects. Obstet Gynecol. 2013 Oct; 122(4):838-44. PMID: 24084542.
    View in: PubMed
  17. Parker SE, Yazdy MM, Tinker SC, Mitchell AA, Werler MM. The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida. Am J Obstet Gynecol. 2013 Sep; 209(3):239.e1-8. PMID: 23711668.
    View in: PubMed
  18. Lind JN, Tinker SC, Broussard CS, Reefhuis J, Carmichael SL, Honein MA, Olney RS, Parker SE, Werler MM. Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007. Pharmacoepidemiol Drug Saf. 2013 Jul; 22(7):783-93. PMID: 23620412.
    View in: PubMed
  19. Parker SE, Werler MM, Shaw GM, Anderka M, Yazdy MM. Dietary glycemic index and the risk of birth defects. Am J Epidemiol. 2012 Dec 15; 176(12):1110-20. PMID: 23171874.
    View in: PubMed
  20. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, Collins JS, Kirby RS, Correa A. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010 Dec; 88(12):1008-16. PMID: 20878909.
    View in: PubMed
  21. Parker SE, Mai CT, Strickland MJ, Olney RS, Rickard R, Marengo L, Wang Y, Hashmi SS, Meyer RE. Multistate study of the epidemiology of clubfoot. Birth Defects Res A Clin Mol Teratol. 2009 Nov; 85(11):897-904. PMID: 19697433.
    View in: PubMed
  22. Sindelar V, Cejas MA, Raymo FM, Chen W, Parker SE, Kaifer AE. Supramolecular assembly of 2,7-dimethyldiazapyrenium and cucurbit[8]uril: a new fluorescent host for detection of catechol and dopamine. Chemistry. 2005 Nov 18; 11(23):7054-9. PMID: 16175642.
    View in: PubMed
Samantha's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department